InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
T+90 hit rate
40%
T+90 mean return
-8.5%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Ruffo Frank, Chief Financial Officer. Insider active across 1 company, notably Aclaris Therapeutics, Inc.. Aggregated, 8 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €211k. Activity tracked since 9 February 2022. The latest transaction was filed on 10 March 2022 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations8 total
12,823 shares@ US$15.54510.029% mcap85.4% of flowCommon StockSEC:0001209191-22-018509:0
25,750 sharesCommon StockSEC:0001209191-22-015809:0
1,388 shares@ US$12.65740.0024% mcap100.0% of flowCommon StockSEC:0001209191-22-008849
1,388 shares@ US$12.65740.0024% mcap7.3% of flowCommon StockSEC:0001209191-22-008849:0
3,875 sharesCommon StockSEC:0001209191-22-006832:0
3,875 sharesCommon StockSEC:0001209191-22-006832
33,189 sharesCommon StockSEC:0001209191-21-037475:0
33,189 sharesCommon StockSEC:0001209191-21-037475
8 of 8 declarations
About Ruffo Frank
Frank Ruffo is the Chief Financial Officer at Aclaris Therapeutics, Inc. He is responsible for the financial management of the company, including budgeting and financial analysis. His role is essential in ensuring the financial health of the organization.
